Amgen (AMGN) PT Raised to $135 at BMO Capital

July 30, 2014 9:11 AM

BMO Capital analyst Jim Birchenough reiterated a Market Perform rating and bumped his price target on Amgen (NASDAQ: AMGN) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found